Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: Lack of significance of secondary cancers

被引:157
作者
Noguchi, M
Stamey, TA
McNeal, JE
Nolley, R
机构
[1] Stanford Univ, Ctr Med, Dept Urol, Stanford, CA 94305 USA
[2] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka, Japan
关键词
prostate; prostatic neoplasms; biopsy; prostate-specific antigen; prostatectomy;
D O I
10.1097/01.ju.0000070928.49986.04
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated secondary cancers in the prostate in relation to predictions of pathological stage and prognosis. Materials and Methods: A total of 222 men with T1c (impalpable) prostate cancer and 6 or more systematic needle biopsies were matched with radical prostatectomy and classified into 3 groups according to tumor multifocality and secondary cancer volumes, including a single tumor in 54 (24%), an index (largest) tumor with secondary cancers less than 0.5 cc in 86 (39%) and an index tumor with secondary cancers greater than 0.5 cc in 82 (37%). Logistic analysis was used to predict adverse histological features. Cox proportional hazards analysis was used to predict prostate specific antigen (PSA) failure after radical prostatectomy. Results: There were no differences among the 3 groups with respect to preoperative serum PSA, number of positive cores, percent Gleason grade 4/5 cancer in the needle biopsy or histological features in radical prostatectomy specimens. On logistic analysis neither serum PSA nor pre-radical biopsy predicted adverse histological features in radical prostatectomy specimens. The Cox regression model showed that primary predictors of PSA failure were percent Gleason grade 4/5 cancer in the biopsy (HR = 2.6, p = 0.015) and prostatectomy (HR = 2.4, p = 0.04) specimens, and the number of positive cores (HR = 2.5, p = 0.04). When comparing PSA failure rates among the 3 groups, the multifocal group with smaller secondary cancers showed a better prognosis than the single tumor group (p = 0.019). Conclusions: Secondary cancers in multifocal prostate tumors did not adversely influence the results of preoperative clinical parameters, including PSA and needle biopsy findings. Percent Gleason grade 4/5 cancer in needle biopsies and prostatectomy specimens is the most powerful predictor of biochemical failure in men with stage T1c prostate cancer after radical prostatectomy.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 21 条
  • [1] Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma
    Conrad, S
    Graefen, M
    Pichlmeier, U
    Henke, RP
    Erbersdobler, A
    Hammerer, PG
    Huland, H
    [J]. JOURNAL OF UROLOGY, 2002, 167 (02) : 521 - 525
  • [2] THE VOLUME OF PROSTATE-CANCER IN THE BIOPSY SPECIMEN CANNOT RELIABLY PREDICT THE QUANTITY OF CANCER IN THE RADICAL PROSTATECTOMY SPECIMEN ON AN INDIVIDUAL BASIS
    CUPP, MR
    BOSTWICK, DG
    MYERS, RP
    OESTERLING, JE
    [J]. JOURNAL OF UROLOGY, 1995, 153 (05) : 1543 - 1548
  • [3] Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Fondurulia, J
    Chen, MH
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Richie, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1164 - 1172
  • [4] CORE CANCER LENGTH IN ULTRASOUND-GUIDED SYSTEMATIC SEXTANT BIOPSIES - A PREOPERATIVE EVALUATION OF PROSTATE-CANCER VOLUME
    DIETRICK, DD
    MCNEAL, JE
    STAMEY, TA
    [J]. UROLOGY, 1995, 45 (06) : 987 - 992
  • [5] Djavan B, 1999, Tech Urol, V5, P139
  • [6] PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER
    EPSTEIN, JI
    WALSH, PC
    CARMICHAEL, M
    BRENDLER, CB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05): : 368 - 374
  • [7] Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score
    Freedland, SJ
    Csathy, GS
    Dorey, F
    Aronson, WJ
    [J]. JOURNAL OF UROLOGY, 2002, 167 (02) : 516 - 520
  • [8] HUMPHREY PA, 1995, CANCER, V75, P1842, DOI 10.1002/1097-0142(19950401)75:7+<1842::AID-CNCR2820751614>3.0.CO
  • [9] 2-2
  • [10] STAGE A VERSUS STAGE-B ADENOCARCINOMA OF THE PROSTATE - MORPHOLOGICAL COMPARISON AND BIOLOGICAL SIGNIFICANCE
    MCNEAL, JE
    PRICE, HM
    REDWINE, EA
    FREIHA, FS
    STAMEY, TA
    [J]. JOURNAL OF UROLOGY, 1988, 139 (01) : 61 - 65